Detalhe da pesquisa
1.
Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma.
Mol Med
; 27(1): 15, 2021 02 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33579185
2.
Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular Carcinoma.
Front Pharmacol
; 12: 691769, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34335258